Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide
Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing its Life Science business’ patent… 19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents... Read more